Department of Ophthalmology, Southern California Permanente Medical Group, Baldwin Park.
Eye Monitoring Center, Kaiser Permanente Southern California, Baldwin Park, California.
JAMA Ophthalmol. 2019 Apr 1;137(4):445-448. doi: 10.1001/jamaophthalmol.2018.6912.
Most patients with diabetes have little or no retinopathy on initial examination. Tracking the long-term outcomes of these patients may increase our understanding of how to best provide follow-up treatment.
To assess how many patients with minimal or no retinopathy require retinal intervention within 2 years of retinal evaluation.
DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study assessed patients who underwent screening for diabetic retinopathy within a telemedicine program at Kaiser Permanente Southern California and had minimal or no retinopathy on fundus photographs.
Retinal interventions performed within 2 years of photographs.
Patients with minimal or no retinopathy on initial screening photographs taken in 2012 had their medical records searched for Current Procedural Terminology codes for intravitreal injections, retinal lasers, or pars plana vitrectomy. The medical records of patients identified as having received these interventions within 2 years of retinal evaluation were then manually reviewed for further characterization.
Diabetic retinopathy screening photographs were taken for 116 134 patients (mean [SD] age, 58 [12.8] years; 54 582 [47.0%] female; 46 453 [40.0%] Latino). Of these patients, 79 445, including 69 634 patients without retinopathy and 9811 patients with minimal retinopathy, had 2 years of follow-up. Eleven patients without baseline retinopathy required treatment of diabetic retinopathy in the following 2 years (1 of 12 660 or 0.000079 patients per year), and 11 patients with minimal retinopathy required intervention during the same period (1 of 1784 or 0.000561 patients per year). In addition, retinal interventions were performed for conditions not directly related to diabetic eye disease in 44 patients without baseline retinopathy (1 of 3165 or 0.000316 patients per year) and 5 patients with minimal retinopathy at baseline (1 of 3924 or 0.000255 patients per year).
These findings suggest that it is rare for patients with minimal or no baseline retinopathy to require retinal interventions in the 2 years after retinal evaluation. It appears that extending the recommended follow-up interval for low-risk patients may be reasonable as long as this does not lead to worse follow-up in later years, because most are unlikely to have vision-threatening disease that necessitates treatment.
大多数糖尿病患者在初次检查时仅有轻微或无视网膜病变。对这些患者的长期结果进行跟踪研究可能会增加我们对如何提供最佳后续治疗的理解。
评估在视网膜评估后 2 年内有多少患有轻微或无视网膜病变的患者需要进行视网膜干预。
设计、地点和参与者:这项回顾性队列研究评估了在 Kaiser Permanente Southern California 的远程医疗计划中接受糖尿病视网膜病变筛查的患者,他们在眼底照片上有轻微或无视网膜病变。
在照片拍摄后 2 年内进行的视网膜干预。
在 2012 年进行的初步筛查照片中患有轻微或无视网膜病变的患者,其病历中搜索了国际疾病分类临床修订版(Current Procedural Terminology)代码,以查找玻璃体腔内注射、视网膜激光或玻璃体切除术。然后,对被确定在视网膜评估后 2 年内接受这些干预的患者的病历进行手动审查,以进一步进行特征描述。
对 116134 名患者(平均[标准差]年龄 58[12.8]岁;54582 名[47.0%]女性;46453 名[40.0%]拉丁裔)进行了糖尿病视网膜病变筛查照片拍摄。在这些患者中,包括 69634 名无视网膜病变患者和 9811 名轻微视网膜病变患者在内的 79445 名患者有 2 年的随访。在接下来的 2 年中,11 名基线无视网膜病变的患者需要治疗糖尿病视网膜病变(112660 人或每年每 0.000079 人),11 名有轻微视网膜病变的患者在同一时期需要进行干预(11784 人或每年每 0.000561 人)。此外,在 44 名基线无视网膜病变的患者(3165 人或每年每 0.000316 人)和 5 名基线有轻微视网膜病变的患者(3924 人或每年每 0.000255 人)中,还对与糖尿病眼病无关的疾病进行了视网膜干预。
这些发现表明,在视网膜评估后 2 年内,有轻微或无基线视网膜病变的患者需要进行视网膜干预的情况很少见。只要这不会导致以后几年的随访情况恶化,延长低风险患者的建议随访间隔可能是合理的,因为大多数患者不太可能患有需要治疗的威胁视力的疾病。